Cleaning Validation MACO Calculator

Derive the Maximum Allowable Carryover for a product changeover using both the health-based (HBEL/PDE) and dose-based criteria, take the most stringent, and get the concentration (ppm), surface (µg/cm²) and per-swab acceptance limits for your cleaning validation.

WHAT THIS CALCULATES

The Maximum Allowable Carryover for a product changeover — how much of the previous product may remain on shared equipment — computed from both the health-based and the traditional dose-based criteria, with the more stringent one governing. It then converts that mass into the limits you can actually sample against: ppm in the next batch, µg per cm² of surface, and µg per swab.

THE METHOD

PDE

Permitted Daily Exposure (or ADE) of the previous product, mg/day — derived toxicologically, not guessed

D

smallest therapeutic daily dose of the previous product, mg

B

minimum batch size of the NEXT product, converted to mg

MDD

maximum daily dose of the next product, mg/day

SF

safety factor for the dose-based criterion — conventionally 1000 for oral solid dosage forms

Derived limits follow from the governing MACO: ppm = MACO / B × 10⁶ · surface limit = MACO × 1000 / sharedArea µg·cm⁻² · swab limit = surface limit × swabArea. Since the 2014 EMA guideline the health-based route is the expected primary criterion; the dose-based 1/1000 rule is retained here because many legacy cleaning programmes are still written against it and the comparison is often the point.

THE INPUTS, AND WHAT THEY MEAN

Previous product PDE / ADE

The health-based limit for the product being cleaned out, mg/day. This comes from a toxicological assessment by a qualified person — it is not a number to estimate, and the assessment is what an inspector asks to see. Set to 0 to skip the HBEL criterion.

Previous product smallest daily dose

The lowest therapeutic daily dose, mg, for the traditional criterion. Set to 0 to skip it.

Safety factor

The divisor in the dose-based criterion. 1000 is the long-standing convention for oral solids; parenteral and more critical routes conventionally use higher factors.

Next product minimum batch size

The SMALLEST batch of the next product, in kg. Smallest, because the residue is diluted into the batch — the smallest batch is the worst case and the one the limit must protect.

Next product max daily dose

The largest daily dose of the next product, mg/day. Largest, because a patient taking more of the next product receives more of the carried-over residue.

Shared surface area

Total product-contact surface of the shared equipment train, cm². Under-counting it produces a surface limit that is too generous.

Swab sampling area

The area each swab covers, cm² — typically 25. It converts the surface limit into the per-swab number the laboratory reports against.

HOW TO READ THE OUTPUT

• ›The most stringent criterion governs. If the health-based limit comes out lower than the dose-based one, HBEL is your limit, and the reverse also holds — the calculator reports which one won and that is what belongs in the protocol.
• ›The derived limits are what the cleaning programme is actually verified against. A MACO in milligrams is not a sampling plan; the µg·cm⁻² and per-swab figures are.
• ›Check the analytical method can reach the limit before adopting it. A swab limit below the method’s quantitation limit is not a limit — it is a validation gap, and it is a common finding.
• ›Worst-case selection sits upstream of all of this. If the wrong product pair was chosen as worst case, every number here is precise and irrelevant.

WORKED EXAMPLE

Changeover from a product with a 0.1 mg/day PDE and a 250 mg smallest dose, into a next product with a 100 kg minimum batch and a 500 mg/day maximum daily dose, over a 200,000 cm² shared train sampled with 25 cm² swabs.

Previous product PDE

0.1 mg/day

Previous smallest daily dose

250 mg (safety factor 1000)

Next product min batch / max daily dose

100 kg / 500 mg/day

Shared area / swab area

200,000 cm² / 25 cm²

The dose-based criterion would have allowed 50,000 mg — two and a half times more. The health-based limit governs at 20,000 mg, which is exactly why the 2014 EMA guideline moved the industry onto HBEL: the traditional 1/1000 rule was the more permissive of the two here, and had no toxicological basis for being so. A programme still running on the dose-based number would be operating at a limit its own PDE does not support.

REGULATORY BASIS

EMA guideline on health-based exposure limits (EMA/CHMP/CVMP/SWP/169430/2012)

Establishes PDE-based limits as the expected basis for shared-facility cleaning limits, replacing dose-fraction rules of thumb.

PIC/S PI 046

Aide-memoire on the assessment of HBEL-based cleaning validation — how inspectors examine the derivation and its application.

21 CFR 211.67

The US requirement to clean and maintain equipment at appropriate intervals to prevent contamination that would alter safety, identity, strength, quality or purity.

EU GMP Chapters 3 and 5

Premises and production requirements on preventing cross-contamination, including the risk-based measures HBEL supports.

LIMITATIONS — READ BEFORE YOU RELY ON THIS

• ›This is an analytical aid, not a validated system. Reproduce the calculation in your own qualified system before it becomes a cleaning acceptance criterion — every formula and conversion is published above so you can.
• ›It does not derive the PDE. That is a toxicological assessment by a qualified assessor, and it is the input an inspector scrutinises hardest — a wrong PDE makes a perfectly executed calculation wrong.
• ›It assumes uniform residue distribution across the shared surface. Real equipment has hard-to-clean locations, and swab sites should target those rather than an average.
• ›It covers chemical carryover only — not cleaning-agent residue, not microbial or endotoxin limits, and not degradants formed by the cleaning process itself.

RELATED ON SPEQ